|
|
Volumn 186, Issue 4, 2011, Pages 1553-1554
|
|
Re: Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APTAMER;
CISPLATIN;
MACROGOL;
NANOPARTICLE;
POLYGLACTIN;
PRODRUG;
PROSTATE SPECIFIC MEMBRANE ANTIGEN;
DNA STRUCTURE;
DRUG ACCUMULATION;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EXPERIMENTAL MODEL;
EXPERIMENTAL MOUSE;
HUMAN;
IN VIVO STUDY;
MAXIMUM TOLERATED DOSE;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
SINGLE DRUG DOSE;
|
|
EID: 80052743579
PISSN: 00225347
EISSN: 15273792
Source Type: Journal
DOI: 10.1016/j.juro.2011.06.017 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
